Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic neoplasm (SM-AHN), the latter accounting for 60-70% of all AdvSM cases. Detection of a dis...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
12 March 2024
|
| In: |
Leukemia
Year: 2024, Volume: 38, Issue: 4, Pages: 699-711 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-024-02182-1 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41375-024-02182-1 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41375-024-02182-1 
|
| Author Notes: | Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Greco Raffaella, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, and Deepti H. Radia |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1897711824 | ||
| 003 | DE-627 | ||
| 005 | 20241205160204.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240805s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-024-02182-1 |2 doi | |
| 035 | |a (DE-627)1897711824 | ||
| 035 | |a (DE-599)KXP1897711824 | ||
| 035 | |a (OCoLC)1475305680 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a McLornan, Donal |e VerfasserIn |0 (DE-588)1337879401 |0 (DE-627)1897714637 |4 aut | |
| 245 | 1 | 0 | |a Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis |b best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee |c Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Greco Raffaella, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, and Deepti H. Radia |
| 264 | 1 | |c 12 March 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.08.2024 | ||
| 520 | |a Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic neoplasm (SM-AHN), the latter accounting for 60-70% of all AdvSM cases. Detection of a disease-triggering mutation in the KIT gene (esp. KIT D816V) in >90% of the patients with ASM or SM-AHN has led to a significant improvement in therapeutic options by the implementation of two KIT-targeting kinase inhibitors: midostaurin and avapritinib. Although complete remissions have been reported, neither of these targeted agents is ‘curative’ in all patients and the duration of responses varies. The median overall survival, depending on the WHO subtype and scoring result, is approximately 1 to 4 years. Although the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) consensus groups recommend allogeneic haematopoietic cell transplantation (allo-HCT) in drug-resistant and other high-risk patients, there is a relative lack of information to guide clinicians on which patients with AdvSM should be considered for transplant, and how KIT inhibitors may fit into the transplant algorithm, including their use pre- and post-transplant to optimise outcomes. Following the generation of an expert panel with a specialist interest in allo-HCT and mastocytosis, these best practice recommendations were generated according to the European Society for Blood and Marrow Transplantation (EBMT) Practice Harmonisation and guidelines and ECNM methodology. We aim to provide a practical, clinically relevant and up-to-date framework to guide allo-HCT in AdvsM in 2024 and beyond. | ||
| 650 | 4 | |a Haematological cancer | |
| 650 | 4 | |a Immunological disorders | |
| 700 | 1 | |a Czerw, Tomasz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Damaj, Gandhi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ethell, Mark |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gurnari, Carmelo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hernández-Boluda, Juan Carlos |e VerfasserIn |4 aut | |
| 700 | 1 | |a Polverelli, Nicola |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schwaab, Juliana |d 1982- |e VerfasserIn |0 (DE-588)1051912687 |0 (DE-627)787019399 |0 (DE-576)407558764 |4 aut | |
| 700 | 1 | |a Sockel, Katja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Raffaella, Greco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Onida, Francesco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sánchez-Ortega, Isabel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Battipaglia, Giorgia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Elena, Chiara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gotlib, Jason |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reiter, Andreas |d 1964- |e VerfasserIn |0 (DE-588)172629551 |0 (DE-627)697563766 |0 (DE-576)133488594 |4 aut | |
| 700 | 1 | |a Rossignol, Julien |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ustun, Celalettin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Valent, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yakoub-Agha, Ibrahim |e VerfasserIn |4 aut | |
| 700 | 1 | |a Radia, Deepti H. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 38(2024), 4, Seite 699-711 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g number:4 |g pages:699-711 |g extent:13 |a Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-024-02182-1 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41375-024-02182-1 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240805 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 172629551 |a Reiter, Andreas |m 172629551:Reiter, Andreas |d 60000 |d 61200 |e 60000PR172629551 |e 61200PR172629551 |k 0/60000/ |k 1/60000/61200/ |p 16 | ||
| 998 | |g 1051912687 |a Schwaab, Juliana |m 1051912687:Schwaab, Juliana |d 60000 |d 61200 |e 60000PS1051912687 |e 61200PS1051912687 |k 0/60000/ |k 1/60000/61200/ |p 8 | ||
| 999 | |a KXP-PPN1897711824 |e 4562721022 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 05.08.2024"],"name":{"displayForm":["Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Greco Raffaella, Francesco Onida, Isabel Sánchez-Ortega, Giorgia Battipaglia, Chiara Elena, Jason Gotlib, Andreas Reiter, Julien Rossignol, Celalettin Ustun, Peter Valent, Ibrahim Yakoub-Agha, and Deepti H. Radia"]},"language":["eng"],"physDesc":[{"noteIll":"Illustrationen","extent":"13 S."}],"title":[{"title_sort":"Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis","subtitle":"best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee","title":"Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis"}],"origin":[{"dateIssuedDisp":"12 March 2024","dateIssuedKey":"2024"}],"id":{"doi":["10.1038/s41375-024-02182-1"],"eki":["1897711824"]},"recId":"1897711824","relHost":[{"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"note":["Gesehen am 15.03.04"],"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group"}],"id":{"issn":["1476-5551"],"eki":["32046699X"],"zdb":["2008023-2"]},"pubHistory":["Nachgewiesen 11.1997 -"],"disp":"Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeLeukemia","part":{"volume":"38","pages":"699-711","issue":"4","extent":"13","year":"2024","text":"38(2024), 4, Seite 699-711"},"recId":"32046699X","type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"role":"aut","family":"McLornan","display":"McLornan, Donal","given":"Donal"},{"given":"Tomasz","role":"aut","display":"Czerw, Tomasz","family":"Czerw"},{"display":"Damaj, Gandhi","family":"Damaj","role":"aut","given":"Gandhi"},{"display":"Ethell, Mark","family":"Ethell","role":"aut","given":"Mark"},{"role":"aut","family":"Gurnari","display":"Gurnari, Carmelo","given":"Carmelo"},{"given":"Juan Carlos","role":"aut","family":"Hernández-Boluda","display":"Hernández-Boluda, Juan Carlos"},{"role":"aut","family":"Polverelli","display":"Polverelli, Nicola","given":"Nicola"},{"role":"aut","display":"Schwaab, Juliana","family":"Schwaab","given":"Juliana"},{"role":"aut","display":"Sockel, Katja","family":"Sockel","given":"Katja"},{"role":"aut","display":"Raffaella, Greco","family":"Raffaella","given":"Greco"},{"display":"Onida, Francesco","family":"Onida","role":"aut","given":"Francesco"},{"given":"Isabel","role":"aut","display":"Sánchez-Ortega, Isabel","family":"Sánchez-Ortega"},{"given":"Giorgia","family":"Battipaglia","display":"Battipaglia, Giorgia","role":"aut"},{"given":"Chiara","role":"aut","display":"Elena, Chiara","family":"Elena"},{"given":"Jason","display":"Gotlib, Jason","family":"Gotlib","role":"aut"},{"given":"Andreas","family":"Reiter","display":"Reiter, Andreas","role":"aut"},{"given":"Julien","display":"Rossignol, Julien","family":"Rossignol","role":"aut"},{"given":"Celalettin","role":"aut","display":"Ustun, Celalettin","family":"Ustun"},{"role":"aut","display":"Valent, Peter","family":"Valent","given":"Peter"},{"role":"aut","display":"Yakoub-Agha, Ibrahim","family":"Yakoub-Agha","given":"Ibrahim"},{"given":"Deepti H.","role":"aut","display":"Radia, Deepti H.","family":"Radia"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a MCLORNANDOALLOGENEIC1220 | ||